Home

ochabnout krev Mandl bladder cancer cd317 metastatic marker slabika organický portugalština

Anti-PD-L1 Abs enhance MPLA-induced pDC activation. a B16 tumor growth... |  Download Scientific Diagram
Anti-PD-L1 Abs enhance MPLA-induced pDC activation. a B16 tumor growth... | Download Scientific Diagram

Novel therapies in urothelial carcinoma: a biomarker-driven approach -  Annals of Oncology
Novel therapies in urothelial carcinoma: a biomarker-driven approach - Annals of Oncology

IJMS | Free Full-Text | Extracellular Vesicles Released from Cancer Cells  Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via  β-Catenin Signaling
IJMS | Free Full-Text | Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling

Exosomes as a new frontier of cancer liquid biopsy | Molecular Cancer |  Full Text
Exosomes as a new frontier of cancer liquid biopsy | Molecular Cancer | Full Text

Cancers | Free Full-Text | Dendritic Cells: Behind the Scenes of T-Cell  Infiltration into the Tumor Microenvironment
Cancers | Free Full-Text | Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment

Metastasis Markers in Bladder Cancer: A Review of the Literature and  Clinical Considerations - ScienceDirect
Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical Considerations - ScienceDirect

TNC and Fsp1 expression in BVI (A, B) Representative images of BVI in... |  Download Scientific Diagram
TNC and Fsp1 expression in BVI (A, B) Representative images of BVI in... | Download Scientific Diagram

Overexpression of the transmembrane protein BST-2 induces Akt and Erk  phosphorylation in bladder cancer
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer

Future directions and management of liquid biopsy in non-small cell lung  cancer
Future directions and management of liquid biopsy in non-small cell lung cancer

Frontiers | Targeted Therapy With Immunoconjugates for Multiple Myeloma
Frontiers | Targeted Therapy With Immunoconjugates for Multiple Myeloma

MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC - S.  Sun, J. Wang, J. Liu, F. Yin, C. Xin, X. Zeng, J. Li, Q. Chen, 2021
MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC - S. Sun, J. Wang, J. Liu, F. Yin, C. Xin, X. Zeng, J. Li, Q. Chen, 2021

The Immunomodulation Potential of Exosomes in Tumor Microenvironment
The Immunomodulation Potential of Exosomes in Tumor Microenvironment

US20210155602A1 - Tetrahydroquinolino derivatives for the treatment of  metastatic and chemoresistant cancers - Google Patents
US20210155602A1 - Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers - Google Patents

Frontiers | The Potential Biomarkers and Immunological Effects of Tumor-Derived  Exosomes in Lung Cancer
Frontiers | The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer

Cancers | Free Full-Text | The Chicken Chorioallantoic Membrane Tumor Assay  as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor  Progression and Metastasis
Cancers | Free Full-Text | The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis

Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High  Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation | PLOS  ONE
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation | PLOS ONE

Cells | Free Full-Text | Dendritic Cells: The Long and Evolving Road  towards Successful Targetability in Cancer
Cells | Free Full-Text | Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer

Cells | Free Full-Text | Human Plasmacytoid Dendritic Cells and Cutaneous  Melanoma
Cells | Free Full-Text | Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma

Frontiers | Increased Expression of SHMT2 Is Associated With Poor Prognosis  and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
Frontiers | Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma

Identification, molecular characterization, clinical prognosis, and  therapeutic targeting of human bladder tumor-initiating cells | PNAS
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | PNAS

In vivo expression profile of the antiviral restriction factor and tumor-targeting  antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS

Overexpression of the transmembrane protein BST-2 induces Akt and Erk  phosphorylation in bladder cancer
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer

Distinguishing primary adenocarcinoma of the urinary bladder from secondary  involvement by colorectal adenocarcinoma: extended immunohistochemical  profiles emphasizing novel markers | Modern Pathology
Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers | Modern Pathology

BST-2 promotes survival in circulation and pulmonary metastatic seeding of  breast cancer cells | Scientific Reports
BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells | Scientific Reports